MyDay® MiSight® 1 day

MyDay® MiSight® 1 day with ActivControl® Technology is indicated for the correction of myopia (short-sightedness) and slowing the progression of myopia.

Affecting nearly 1 in 3 children globally,‡4 myopia is influenced by factors like genetics, too much time on close-up activities, and insufficient outdoor play.5,6 If left untreated, it can impact a child’s quality of life, 7,8 their academic performance and athletics,9-14 and even limit future career options, such as becoming a pilot or firefighter.1

Fortunately, your child may be able to benefit from an innovative technology to help slow down the worsening of their myopia.†1-3 MyDay® MiSight® 1 day contact lenses are designed to do more than just correct vision, they also help slow the worsening of myopia,1-3 and while traditional glasses and contact lenses provide clear vision, they don't slow down the rate at which myopia worsens.

Features and Benefits

  • Features ActivControl® Technology which works for nearly all children with myopia§3,16 and is shown to slow the worsening of myopia by approximately half.◊3,17
  • MyDay® MiSight® 1 day contact lenses are made from a naturally wettable material that locks in moisture to help provide all-day comfort.3 In fact, 100% of children studied were happy with the overall comfort of the lenses.¶2
  • MyDay® MiSight® 1 day contact lenses are designed specifically for children**1,2,16,18 and 97% of children studied were able to successfully handle the lenses.††2
  • Convenient one-day contact lenses— no need to clean or store them.

Unsure which products are best for you?

Take this four question quiz to discover which of our products may best fit your needs.

Find Your Lens

For the device safety, warnings, precautions, and local regulatory information, please refer to the Instruction for Use leaflet

†MyDay® MiSight® 1 day contact lenses use the same ActivControl® Technology as the original MiSight® 1 day.
‡ Based on a comprehensive analysis of 276 studies, involving a total of 5,410,945 children and adolescents with spherical equivalent of -0.50D or less, aged 6-19 from across 50 countries, with notable variations in prevalence across different demographic groups.
§90% of myopic eyes respond to treatment with MiSight® 1 day (ages 11-15 at start of wear, n=90), which shares the same ActivControl® Technology with MyDay® MiSight® 1 day
◊ Using measured and modeled data, pooled across ages (8-17), myopia progression was slowed by an average of approximately 50% with MiSight® 1 day, which shares the same ActivControl® Technology with MyDay® MiSight® 1 day
¶ Clinical study participants at the 1-week visit. 38% rated very happy, 53% rated happy, 9% rated slightly happy with overall comfort satisfaction
** Based on adherence to replacement schedule, lens handling, comfort, satisfaction, vision quality, and visual acuity findings.
††After 1 week of daily wear, 41% rated Excellent (no problems with lens application and removal), 34% rated Very good (occasional difficulty with application and removal), 22% rated Good (some problems but application and removal but usually successful)

References
1. Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. OVS 2019; 96(8):556-567.
2. CVI data on file, 2025. Prospective, 1-week, double masked, bilateral study with MyDay MiSight 1 day. N=32 subjects aged 8-18 years.
3. CVI data on file, 2025
4. Liang J, Pu Y, Chen J, et al, Global prevalence, trend and projection of myopia in children and adolescents from 1990 to 2050: a comprehensive systematic review and meta-analysis, British Journal of Ophthalmology, Published Online First: 24 September 2024
5. Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036-1042.
6. Jones LA, Sinnott LT, Mutti DO, Mitchell GL, Moeschberger ML, Zadnik K. Parental history of myopia, sports and outdoor activities, and future myopia. Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3524-32.
7. E. L. Lamoureux, J. Wang, T. Aung, S. M. Saw, T. Y. Wong; Myopia and Quality of Life: The Singapore Malay Eye Study (SiMES). Invest. Ophthalmol. Vis. Sci. 2008;49(13):4469.
8. Chua S.Y.L., Foster P.J. (2020) The Economic and Societal Impact of Myopia and High Myopia. In: Ang M., Wong T. (eds) Updates on Myopia. Springer, Singapore.
9. Ma X, et al. Effect of providing free glasses on children's educational outcomes in China: cluster randomized controlled trial. BMJ. 2014 Sep 23;349:g5740.
10. Jan C, Li S, Kang M, et al. Association of visual acuity with educational outcomes: a prospective cohort study. British Journal of Ophthalmology 2019;103:1666-1671
11. Yadav R, et al. Vision Related Quality of Life, Sports Activities and Academic Performance Among Myopic School Going children: A Cross Sectional Study. African Journal of Biomedical Research 2024; 27(1S), 2228-2231.
12.Sankaridurg P, Tahhan N, Kandel H, et al. IMI Impact of myopia. Invest Ophthalmol Vis Sci. 2021;62(5):2. pg 6.
13.Shams N, Mobaraki H, Kamali M, Jafarzadehpour E. Comparison of quality of life between myopic patients with spectacles and contact lenses, and patients who have undergone refractive surgery. J Curr Ophthalmol. 2015 Nov 17;27(1-2):32-6.
14.Pan C-W, Ramamurthy D & Saw S-M. Worldwide prevalence and risk factors for myopia. Ophthalmic Physiol Opt 2012, 32, 3-16.
15. Vision standards and requirements. Association of Optometrists. (n.d.). Accessed October 30, 2025, from https://www.aop.org.uk/advice-and-support/clinical/vision-standards
16. Chamberlain P, et al. Long-term Effect of Dual-focus Contact Lenses on Myopia Progression in Children: A 6-year Multicenter Clinical Trial. OVS 2022 Mar 1;99(3):204-212
17. Arumugam B et al. Modelling Age Effects of Myopia Progression for the MiSight 1 day Clinical Trial. IOVS 2021;62(8):2333.
18. CVI data on file, 2024
19. Chamberlain P, Arumugam B, et al. Myopia progression on cessation of Dual-Focus contact lens wear: MiSight 1 day 7 year findings. OVS 2021;98:E-abstract 210049

SA15976 _1b CVY03261763-1